EP3554511
Title:
COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3554511
WO Application Number:
AU2017051402
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17880962.0
WO Publication Number:
WO2018107244
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Australia (AU)
Publications:
Dates
Filing date:
15/12/2017
Grant date:
10/07/2024
EP Publication Date:
23/10/2019
WO Publication Date:
21/06/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
10/07/2024
EP B1 Publication Date:
10/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/12/2037
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
10/07/2024
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
10/07/2024
Name:
Progen PG500 Series Pty Ltd
Address:
184 Moorabool Street, Geelong, Victoria 3220, Australia (AU)